Zobrazeno 1 - 1
of 1
pro vyhledávání: '"R L Perin"'
Autor:
A Z Dotti, E G Vilela, J M F Chebli, L A Chebli, D O Magro, F Steinwurz, M Argollo, N S Carvalho, J M L Parente, R S Parra, R L Perin, C Flores, E M Morsoletto, S D C Ferreira, J C Ludvig, R L Kaiser Jr, N S F Queiroz, M A G Faria, G M Nicollelli, A R Andrade, P G Kotze
Publikováno v:
Journal of Crohn's and Colitis. 17:i714-i715
Background Vedolizumab, a human monoclonal antibody that blocks integrin α4-β7, was approved for the management of Inflammatory Bowel Diseases. In real-world experience the number of patients using vedolizumab as first-line biological therapy was l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d991fbf3781dc2731b42df83cb4dafbe
https://doi.org/10.1093/ecco-jcc/jjac190.0716
https://doi.org/10.1093/ecco-jcc/jjac190.0716
